← Open Payments lookup

MICHELLE LYNOTT: Open Payments

NPI 1881887339 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,135 in 81 payments from 16 companies in 2025. Trend: 2023 $2,034 · 2024 $1,583 · 2025 $2,135

Food & beverage: $2,135
CompanyPaymentsAmount
Madrigal Pharmaceuticals9$507
ABBVIE INC.19$408
Gilead Sciences, Inc.11$265
Takeda Pharmaceuticals U.S.A., Inc.8$236
Janssen Biotech, Inc.8$153
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$103
Lilly USA, LLC3$79
Aimmune Therapeutics, Inc.4$75
Ipsen Biopharmaceuticals, Inc3$70
Intercept Pharmaceuticals, Inc.3$61

Products named: REZDIFFRA, ENTYVIO, LINZESS, TREMFYA, SKYRIZI, XIFAXAN, OMVOH, ZENPEP.

Industry payments across AZ — which companies pay providers there.